{
    "Trade/Device Name(s)": [
        "HomeCheck Rapid Multiple(X) Abuse Drug Screen Test Cup Device",
        "HomeCheck\u2122 Multiple Drug Cup Test"
    ],
    "Submitter Information": "Tianjin New Bay Bioresearch Co., Ltd.",
    "510(k) Number": "K071489",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052882"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "LDJ",
        "DIO",
        "DJC",
        "DJR",
        "DJG",
        "LCM",
        "LFH"
    ],
    "Summary Letter Date": "March 14, 2008",
    "Summary Letter Received Date": "March 17, 2008",
    "Submission Date": "Jan 23, 2008",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine, Methamphetamine, Benzoylecgonine, Benzodiazepine, Marijuana, Morphine, Phencyclidine, Methadone, Oxycodone, Tricyclic Antidepressant, and Barbiturates test system",
        "Amphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Methamphetamine",
        "Benzoylecgonine",
        "Benzodiazepine",
        "Marijuana",
        "Morphine",
        "Phencyclidine",
        "Methadone",
        "Oxycodone",
        "Tricyclic Antidepressant",
        "Barbiturates"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Colloidal gold-labeled antibody conjugate"
    ],
    "Methodologies": [
        "Qualitative immunoassay",
        "Chromatographic absorbent strip"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test Cup",
        "Strip"
    ],
    "Document Summary": "FDA 510(k) summary for HomeCheck Rapid Multiple Abuse Drug Screen Test Cup Device for qualitative detection of multiple drugs of abuse in human urine by immunochromatographic assay",
    "Indications for Use Summary": "Provides a qualitative analytical screening procedure for detecting single or multiple drugs of abuse in human urine, intended for OTC consumer use with recommendation for confirmatory testing by GC/MS or HPLC.",
    "fda_folder": "Toxicology"
}